Isocarboxazid Tablet
Brand names: Marplan
Category: Psychiatry
FDA status: Current · Last FDA update: Aug 6, 2026 · First posted: Apr 16, 2026 (in shortage 5 months) · 1 manufacturers, 1 listed presentations
As of Aug 6, 2026, the FDA lists Isocarboxazid Tablet as currently in shortage. Of 1 manufacturer presentations, 1 Limited.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) NDC 72336-032-01 |
Lifsa Drugs LLC | Limited | Estimated recovery: TBD |
Related medications in shortage
Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Isocarboxazid Tablet (FDA data as of Aug 6, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Isocarboxazid Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/isocarboxazid-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).